138026-93-4 Usage
General Description
(4aS*,7aR*)-tert-butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate is a chemical compound with the molecular formula C13H21NO3. It is a tert-butyl ester derivative of a hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylic acid. (4aS*,7aR*)-tert-butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate is a cyclic organic substance that contains a six-membered heterocyclic ring with a nitrogen and an oxygen atom. It can be used as a building block in organic synthesis and has potential pharmaceutical applications. Its unique structure and functional groups make it a valuable intermediate for the synthesis of various biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 138026-93-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,0,2 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 138026-93:
(8*1)+(7*3)+(6*8)+(5*0)+(4*2)+(3*6)+(2*9)+(1*3)=124
124 % 10 = 4
So 138026-93-4 is a valid CAS Registry Number.
138026-93-4Relevant articles and documents
HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
-
, (2021/06/26)
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
Tetrahydroisoquinoline compound and its preparation method, pharmaceutical composition and use
-
Paragraph 0210; 0215, (2018/03/24)
The invention relates to a tetrahydroisoquinoline compound and its preparation method, pharmaceutical composition and use. The tetrahydroisoquinoline compound is shown by the general formula (1). In the general formula (1), the symbols have the same definitions as in the specification.
DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY
-
, (2017/02/28)
The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D3 receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.
